| 000 | 01459 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516123035.0 | ||
| 264 | 0 | _c20130723 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1096-0961 | ||
| 024 | 7 |
_a10.1016/j.bcmd.2012.11.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZáčková, Markéta | |
| 245 | 0 | 0 |
_aHsp90 - a potential prognostic marker in CML. _h[electronic resource] |
| 260 |
_bBlood cells, molecules & diseases _cMar 2013 |
||
| 300 |
_a184-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBiomarkers, Tumor |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xgenetics |
| 650 | 0 | 4 |
_aHSP90 Heat-Shock Proteins _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aK562 Cells |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMoučková, Darina | |
| 700 | 1 | _aLopotová, Tereza | |
| 700 | 1 | _aOndráčková, Zuzana | |
| 700 | 1 | _aKlamová, Hana | |
| 700 | 1 | _aMoravcová, Jana | |
| 773 | 0 |
_tBlood cells, molecules & diseases _gvol. 50 _gno. 3 _gp. 184-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bcmd.2012.11.002 _zAvailable from publisher's website |
| 999 |
_c22300308 _d22300308 |
||